Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system

Blood. 2014 Sep 18;124(12):1998-2000. doi: 10.1182/blood-2014-04-568121. Epub 2014 Jun 24.

Authors

Hong Wang¹, Fenglin Cao², Jinmei Li¹, Limin Li¹, Yong Li³, Ce Shi¹, Wenjia Lan¹, Dandan Li¹, Hui Zhao¹, Ying Zhang¹, Zhuo Zhang¹, Xiuhua Liu¹, Ran Meng¹, Baofeng Yang¹, Jin Zhou²

Affiliations

¹ Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China.
² Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Heilongjiang Institute for Hematology and Oncology Research, Harbin, China.
³ Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Department of Hematology, Radiology Branch, First Affiliated Hospital, Harbin Medical University, Harbin, China.

No abstract available

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Arsenic Trioxide
Arsenicals / administration & dosage*
Arsenicals / cerebrospinal fluid
Blood-Brain Barrier / drug effects
Central Nervous System Neoplasms / cerebrospinal fluid
Central Nervous System Neoplasms / drug therapy*
Child
Female
Humans
Induction Chemotherapy
Leukemia, Promyelocytic, Acute / cerebrospinal fluid
Leukemia, Promyelocytic, Acute / drug therapy*
Male
Mannitol / administration & dosage*
Middle Aged
Oxides / administration & dosage*
Oxides / cerebrospinal fluid
Recurrence
Remission Induction
Young Adult

Substances

Arsenicals
Oxides
Mannitol
Arsenic Trioxide

Associated data

ISRCTN/ISRCTN94954912